Potential Role of Upadacitinib in Cytomegalovirus Colitis Recurrence.

Eur J Case Rep Intern Med · 2025 · PMC12061224 · PMID 40352699

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although CMV colitis recurrence due to worsening UC was considered, it was ruled out as UC showed a trend of improvement with upadacitinib administration.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.